WASHINGTON — The skyrocketing cost of insulin is leading to a push for a generic version of the medicine. Diabetics have testified before Congress about the impact of rising prices on the lifesaving ...
WASHINGTON (Reuters) - Generic drugmakers are furiously campaigning against a proposed U.S. rule that would require them to change the prescribing information on their products if they receive new ...
(Reuters) - The U.S. Food and Drug Administration on Tuesday defended its proposal to require generic drugmakers to update the prescribing information on their products if they become aware of new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results